Clinical Trial Update: Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia [Phase 3]

View source ↗

Summary

PATH-sponsored Phase 3 clinical trial in Ethiopia evaluating targeted antimalarial drug administration for seasonal migrant populations in the Amhara region.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Snippet

Sponsor: PATH | Conditions: Plasmodium Falciparum, Malaria | Phase 3 | Status: ACTIVE_NOT_RECRUITING